Company News

bioMérieux, a world leader in the field of in vitro diagnostics, announces the approval of the cutting-edge diagnostic assay for the detection of pathogenic E. coli., a bacterium that is commonly found in the human gastrointestinal tract.

bioMérieux, a world leader in the field of in vitro diagnostics announced today the launch of GENE-UP^® PRO ACB, a new assay for juice quality and safety programs.

Bringing an added level of confidence to the robust science that its assay offers, the bioMérieux, Inc. GENE-UP^® NUTRAPLEX PRO™ multiplex pathogen detection assay has achieved the AOAC® Research Institute Performance Tested Methods℠ approval (PTM 082103).

bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce that it has received AOAC INTERNATIONAL Performance Tested Method℠ approval for its GENE-UP® PRO STEC / Salmonella assay, for the simultaneous enrichment and detection of STEC (Shiga Toxigenic Escherichia coli) and Salmonella spp. in cannabis samples.

Salmonella detection has been a main-stay requirement in the food industry to prevent foodborne illness. While enrichment-based assays for the Presence / Absence detection of food pathogens are still vital to a safe and abundant global food supply, the food industry has longed for an easy to use and reliable diagnostic solution to accurately quantify levels of Salmonella to aid in process and product disposition decisions at the operational level.